Heterodimeric Antibody Chain Pairing Using Electrostatic Steering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The challenge in producing heterodimeric antibodies lies in achieving robust and homogeneous pairing of heavy and light chains, as existing methods result in random pairing and the generation of mispaired contaminants, which affects manufacturability and biological efficacy.

Innovation Solution

The application of electrostatic steering mechanisms to engineer heavy and light chains by mutating interface residues to favor correct pairing, using specific amino acid substitutions at positions 39, 147, and 165 for VH and CH1 domains, and positions 38, 124, and 169/170 for VL and CL domains, creating a 'clip-effect' that stabilizes the protein and promotes heterodimer formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If heavy and light chains are co-expressed in the same cell to assemble heterodimeric antibodies, then bispecific antibody production is enabled, but random pairing and mispaired contaminants are generated

Engineering Contradiction:
Improvebisspecific antibody productionVSAvoidheavy chain-light chain pairing homogeneity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies local quality by introducing charged residues at specific positions (39, 147, 165 in VH/CH1 and 38, 124, 169/170 in VL/CL) to create localized electrostatic steering mechanisms. These targeted modifications create specific interaction zones that guide correct heavy-chain/light-chain pairing while maintaining overall protein function.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes the electrostatic parameter of the antibody interface by introducing charged amino acid residues. This parameter change creates electrostatic steering forces that selectively promote correct pairing combinations, transforming the random pairing process into a directed assembly process with high homogeneity.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If interface residues are mutated to promote correct pairing, then pairing homogeneity is improved, but protein stability may be affected

Engineering Contradiction:
Improveheavy chain-light chain pairing homogeneityVSAvoidprotein interface stability
Core Design Contradiction:
Manufacturing precisionVSStability of the object's composition

Solution Approach 1:

The charged residues act as intermediary elements that mediate the interaction between heavy and light chains. These intermediate charged groups create electrostatic steering forces that guide pairing without forming direct covalent bonds, thus maintaining protein stability while achieving homogeneous pairing.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the electrostatic parameter at the protein interface by introducing charged residues. This parameter change creates long-range electrostatic steering forces that guide correct pairing while the actual bonding maintains traditional hydrophobic and hydrogen bonding interactions, preserving protein stability.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If charged residues are introduced at the end of domains to create salt bridges, then correct pairing is favored through clip-effect, but manufacturing complexity increases

Engineering Contradiction:
Improvecorrect heavy-light chain pairingVSAvoidcharge engineering complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-calculating and pre-designing the optimal positions for charged residues based on structural analysis. The positions (39, 147, 165 in VH/CH1 and 38, 124, 169/170 in VL/CL) were selected in advance to create the clip-effect, eliminating the need for complex iterative optimization during manufacturing.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent applies local quality by concentrating the charge engineering modifications at specific, strategically chosen positions at the domain ends rather than uniformly distributing modifications. This localized approach creates the clip-effect at critical pairing zones while minimizing overall manufacturing complexity.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the pairing of heavy and light chains, resulting in stable heterodimeric antibodies with reduced mispairing, facilitating efficient production and easy identification of correctly paired molecules through electrophoresis.

Implementation Method 1

electrostatic steering mechanisms were applied to engineer the heavy and light chains of a subset of antibodies and antibody fragments. Interface residues were mutated in such a way that each light chain strongly favoured its cognate heavy chain

Methodology Applied
Scientific EffectElectrostatic steering: Electrostatics

Implementation Method 2

choosing positions at the rim of this interface, it was possible to achieve an effect that strongly favours heterodimeric formation by creating salt bridges at the ends of the domains and thereby generating a 'clip-effect' that closes the correct heavy-light chain formation

Methodology Applied
Scientific EffectSalt bridge: Electrostatics

Implementation Method 3

facilitating efficient production and easy identification of correctly paired molecules through electrophoresis

Methodology Applied
Scientific EffectElectrophoresis: Electrophoresis

Data Source

PatentUS20260062477A1Engineered Heterodimeric Proteins
Publication Date: 2026.03.05 NOVARTIS PHARMA AG
  • US20260062477A1 patent drawing

AI summary

The present invention provides heterodimeric antibodies and fragments thereof and methods for their preparation, wherein the pairing of heavy and light chains has been improved. Interface residues were mutated such that each light chain strongly favoured its cognate heavy chain when two different heavy chains and two different light chains were co-transfected and co-expressed in the same cell to assemble a functional, heterodimeric antibody or fragment thereof.